HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic intermittent electronic cigarette exposure induces cardiac dysfunction and atherosclerosis in apolipoprotein-E knockout mice.

Abstract
Electronic cigarettes (e-cigarettes), also known as electronic nicotine delivery systems, are a popular alternative to conventional nicotine cigarettes, both among smokers and those who have never smoked. In spite of the widespread use of e-cigarettes and the proposed detrimental cardiac and atherosclerotic effects of nicotine, the effects of e-cigarettes on these systems are not known. In this study, we investigated the cardiovascular and cardiac effects of e-cigarettes with and without nicotine in apolipoprotein-E knockout (ApoE-/-) mice. We developed an e-cigarette exposure model that delivers nicotine in a manner similar to that of human e-cigarettes users. Using commercially available e-cigarettes, bluCig PLUS, ApoE-/- mice were exposed to saline, e-cigarette without nicotine [e-cigarette (0%)], and e-cigarette with 2.4% nicotine [e-cigarette (2.4%)] aerosol for 12 wk. Echocardiographic data show that mice treated with e-cigarette (2.4%) had decreased left ventricular fractional shortening and ejection fraction compared with e-cigarette (0%) and saline. Ventricular transcriptomic analysis revealed changes in genes associated with metabolism, circadian rhythm, and inflammation in e-cigarette (2.4%)-treated ApoE-/- mice. Transmission electron microscopy revealed that cardiomyocytes of mice treated with e-cigarette (2.4%) exhibited ultrastructural abnormalities indicative of cardiomyopathy. Additionally, we observed increased oxidative stress and mitochondrial DNA mutations in mice treated with e-cigarette (2.4%). ApoE-/- mice on e-cigarette (2.4%) had also increased atherosclerotic lesions compared with saline aerosol-treated mice. These results demonstrate adverse effects of e-cigarettes on cardiac function in mice.NEW & NOTEWORTHY The present study is the first to show that mice exposed to nicotine electronic cigarettes (e-cigarettes) have decreased cardiac fractional shortening and ejection fraction in comparison with controls. RNA-seq analysis reveals a proinflammatory phenotype induced by e-cigarettes with nicotine. We also found increased atherosclerosis in the aortic root of mice treated with e-cigarettes with nicotine. Our results show that e-cigarettes with nicotine lead to detrimental effects on the heart that should serve as a warning to e-cigarette users and agencies that regulate them.
AuthorsJorge Espinoza-Derout, Kamrul M Hasan, Xuesi M Shao, Maria C Jordan, Carl Sims, Desean L Lee, Satyesh Sinha, Zena Simmons, Norma Mtume, Yanjun Liu, Kenneth P Roos, Amiya P Sinha-Hikim, Theodore C Friedman
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 317 Issue 2 Pg. H445-H459 (08 01 2019) ISSN: 1522-1539 [Electronic] United States
PMID31172811 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA, Mitochondrial
  • Nicotinic Agonists
  • Reactive Oxygen Species
  • Nicotine
Topics
  • Animals
  • Atherosclerosis (etiology, genetics, metabolism, pathology)
  • DNA, Mitochondrial (genetics, metabolism)
  • Disease Models, Animal
  • Electronic Nicotine Delivery Systems
  • Inhalation Exposure (adverse effects)
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout, ApoE
  • Mutation
  • Myocytes, Cardiac (metabolism, ultrastructure)
  • Nicotine (toxicity)
  • Nicotinic Agonists (toxicity)
  • Oxidative Stress
  • Plaque, Atherosclerotic
  • Reactive Oxygen Species (metabolism)
  • Stroke Volume
  • Transcriptome
  • Vaping (adverse effects)
  • Ventricular Dysfunction, Left (etiology, genetics, metabolism, physiopathology)
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: